DHA and VelocityTX Collaborate to Revolutionize Military Medicine
San Antonio, Thursday, 25 September 2025.
The Defense Health Agency partners with VelocityTX to advance military medical innovation, focusing on translational science and collaboration, enhancing healthcare for military personnel and veterans.
Strategic Partnership for Healthcare Innovation
In a groundbreaking development, the Defense Health Agency (DHA) has formalized a strategic partnership with VelocityTX, a nonprofit bioscience innovation campus based in San Antonio, Texas. This collaboration, announced on September 23, 2025, is designed to propel military medical innovation by leveraging translational science, agile infrastructure deployment, and enhanced cross-sector collaboration [1][2].
Integration and Unified Framework
The partnership aims to consolidate existing independent research and development efforts, including those with the U.S. Army Institute of Surgical Research and the 59th Medical Wing, under a unified, mission-aligned framework. This integration is expected to streamline processes, reduce redundancy, and boost the efficiency of innovation in military medicine [1].
Events and Collaborations Driving Innovation
In May 2025, the DHA and VelocityTX hosted the second annual Promoting Professional Engagement Among Military Medical Laboratories (ProPEL) event, alongside the AIM Health R&D Summit. These events facilitate research collaborations and synergy between the public and private sectors, furthering advancements in healthcare solutions aligned with DHA priorities [1][3].
Long-term Impact and Future Directions
The strategic partnership is poised to transform the landscape of military medicine by driving dual-use innovations and enhancing warfighter readiness. By establishing VelocityTX as a trusted operational hub, the collaboration underscores DHA’s commitment to real-time, real-world readiness, ensuring that military personnel and veterans receive cutting-edge medical care [1][3].